Clinical Trial Update: A 2-Part Study to Investigate the Dose-Ranging Safety and Pharmacokinetics, Followed by the Efficacy and Safety of ZX008 (Fenfluramine Hydrochloride) Oral Solution as an Adjunctive Therapy in Children ≥ 2 Years Old and Young Adults With Dravet Syndrome [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ZX008 (fenfluramine hydrochloride) oral solution as adjunctive therapy in children 2 years and older with Dravet syndrome; study comple…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dravet Syndrome

Drugs mentioned

• ZX008 (fenfluramine hydrochloride)

Snippet

Sponsor: Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. | Conditions: Dravet Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2022-10-19